Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Motor Activity 15Breast Neoplasms 10Neoplasms 7Fatigue 7Cognitive Dysfunction 3Lung Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Stomach Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Parasomnias 1Obesity 1Multiple Endocrine Neoplasia Type 1 1Metabolic Syndrome 1Lymphoma, Follicular 1Liver Neoplasms 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1Asthenia 1Arthritis 1Arthralgia 1Adenomatous Polyps 1

Interventions

Cyclophosphamide 176Rituximab 164fludarabine phosphate 97Peripheral Blood Stem Cell Transplantation 95Filgrastim 73Etoposide 67Radiotherapy 63Mycophenolic Acid 62Whole-Body Irradiation 58Tacrolimus 49Melphalan 49Cyclosporine 49Busulfan 47Lenalidomide 45Antilymphocyte Serum 39Vincristine 37Prednisone 37Cytarabine 37fludarabine 35Methotrexate 33Carmustine 32obinutuzumab 31Doxorubicin 30Bendamustine Hydrochloride 30Methylprednisolone 27ibritumomab tiuxetan 25Cord Blood Stem Cell Transplantation 25sargramostim 24Bortezomib 24Granulocyte Colony-Stimulating Factor 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphoma, Follicular × Walking × Clear all
NCT06495190 2025-03-12

Cognition, Flavonoids, Exercise, Gut Microbiome

Appalachian State University

Phase NA Recruiting
240 enrolled
Lymphoid

Lymphoma, Follicular, Motor Activity, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡